In the pre‐treatment samples, we found that the TRG 1–3 group had a higher density of PD‐L1/CD68 double‐positive cells in the tumor parenchyma than the TRG 4–5 group (p = 0.048) (Figure 1). This evidence concerns the gene CD68 and neoplasm.